Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Urol Oncol. 2018 Sep 17;36(11):501.e1–501.e8. doi: 10.1016/j.urolonc.2018.06.011

Table 1:

Demographic, clinical information and biopsy outcomes stratified by race

Continuous Variables Black
(N = 287)
Non-Black
(N = 277)
p
Value1
Median [IQR] Median [IQR]

Age, years 61.00 (56.00−66.00) 62.00 (57.00−66.00) 0.34
Body Mass Index, kg/m2 27.5 (24.4−31.7) 27.1 (24.4−29.8) 0.21
2Serum PSA, ng/mL 8.10 (5.60−16.10) 5.63 (4.20−10.00) <0.001
Prostate volume, cm3 41.4 (30.0−59.0) 42.4 (28.6−62.1) 0.71
PSA density, ng/mL/cm3 0.22 (0.13−0.48) 0.15 (0.09−0.24) <0.001
Free PSA, % 11.0 (8.4−20.4) 16.0 (9.5−21.3) 0.17
West African Ancestry, % 80.4 (70.4−86.4) 4.7(2.3−7.8) <0.001
Annual Income (×1000) $20 ($10−$30) $30 ($10−$40) <0.001

Categorical Variables Black
(N = 287 )
Non-Black
(N = 277 )
p
Value3
N (%) N (%)

Recruitment Site
· Cook County4 235 (81.9) 131 (47.3) <0.001
· JBVAMC4 16 (5.6) 6 (2.1)
· UIC4 5 (1.7) 1 (0.4)
· Northwestern5 27 (9.4) 131 (47.3)
· U of Chicago5 4 (1.4) 8 (2.9)
Clinical Risk Factors
Abnormal DRE 95 (33.1) 85 (30.7) 0.56
Family History 45 (15.7) 61 (22.0) 0.05
5-ARI use (current) 33 (11.5) 34 (12.3) 0.78
History of Clinical BPH 106 (36.9) 126 (45.5) 0.04
Substance Use History
Alcohol use (>10 drinks per week regularly) 241 (84.0) 235 (84.8)| 0.69
Tobacco use (ever, >100cigs) 186 (64.8) 155 (56.0)
0.04
Sociodemographic
Factors
High School Completed 116 (40.4) 159 (57.4) <0.001
Married 112 (39.0) 200 (72.2) <0.001
1

Using Mann-Whitney U-tests;

2

PSA was doubled for 5-a-reductase inhibitor use;

3

Using χ2 tests;

4

bold type indicates p <0.05; Publicly funded sites;

5

Privately funded sites